Bulletin
Investor Alert

New York Markets After Hours

CEL-SCI Corp.

ASE: CVM

GO
/marketstate/country/us

After Hours

CVM
/zigman2/quotes/203889380/composite

$

12.50

Change

+0.18 +1.46%

Volume

Volume 1,005

Sep 29, 2020, 4:29 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203889380/composite

Today's close

$ 12.00

$ 12.32

Change

+0.32 +2.67%

Day low

Day high

$12.09

$12.59

Open
Open: 12.19

52 week low

52 week high

$6.00

$18.00

Open

Market cap

$463.49M

Average volume

481,816

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.82

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cvm

MarketWatch News on CVM

  1. Friday's biggest gaining and declining stocks

    5:27 p.m. Nov. 6, 2009

    - MarketWatch

  2. Drug stocks edge higher; Alkermes slides

    3:38 p.m. Nov. 6, 2009

    - Val Brickates Kennedy

  3. Stocks in the Spotlight Friday

    11:59 p.m. April 7, 2006

    - Barron's Online

  4. CEL-SCI Corp. down 14% at $1.48

    9:32 a.m. April 5, 2006

    - Tomi Kilgore

  5. St. Jude Medical, Ciena shares active in late trade

    7:04 p.m. April 4, 2006

    - Scott Banerjee

  6. Cel-Sci submits Phase III trial protocol for Multikine

    10:03 a.m. Jan. 4, 2005

    - Tomi Kilgore

  7. CEL-SCI Q2 rev $81,532 vs $61,878

    12:24 p.m. Aug. 16, 2004

    - Heather Wilson

  8. CEL-SCI Q2 net loss 1c vs loss 3c

    12:23 p.m. Aug. 16, 2004

    - Heather Wilson

  9. Cel-Sci shares soar on Multikine trial results

    10:30 a.m. Dec. 8, 2003

    - Tomi Kilgore

  10. Cel-Sci sees poitive results for Multikine cancer drug

    8:20 a.m. Dec. 8, 2003

    - Ciara Linnane

  11. CEL-SCI Corp to seek new clinical trials for Multikine

    9:25 a.m. July 28, 2003

    - Greg Robb

  12. Charting the Market

    1:01 a.m. Feb. 21, 2000

    - Barron's Online

/news/nonmarketwatch/company/us/cvm

Other News on CVM

  1. 10-Q/A: CEL SCI CORP

    6:06 a.m. Aug. 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. 10-Q: CEL SCI CORP

    5:27 p.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. Cel-Sci up 5% on positive data on COVID-19 conjugates

    12:35 p.m. July 24, 2020

    - Seeking Alpha

  4. Stocks To Watch: Bank Earnings And SPAC Deals Blaze In

    8:25 a.m. July 11, 2020

    - Seeking Alpha

  5. CEL-SCI: What's Next

    9:40 p.m. May 25, 2020

    - Seeking Alpha

  6. Cel-Sci: A Zombie Biotech Company

    9:00 a.m. May 23, 2020

    - Seeking Alpha

  7. CEL-SCI's Multikine: Can It Really Be This Good?

    10:26 p.m. May 17, 2020

    - Seeking Alpha

  8. 10-Q: CEL SCI CORP

    5:27 p.m. May 8, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Cel-Sci almost there with late-stage Multikine study

    9:45 a.m. May 4, 2020

    - Seeking Alpha

  10. CGC, STWD among premarket gainers

    9:13 a.m. May 4, 2020

    - Seeking Alpha

  11. Cel-Sci: It's All Happening

    4:25 p.m. April 15, 2020

    - Seeking Alpha

  12. IVR, NYMT among premarket losers

    9:13 a.m. March 24, 2020

    - Seeking Alpha

  13. Healthcare firms announce Covid-19-related actions

    9:15 a.m. March 23, 2020

    - Seeking Alpha

  14. Cel-Sci: LEAPS And COVID-19

    1:53 p.m. March 10, 2020

    - Seeking Alpha

  15. INO, OPK among premarket gainers

    9:12 a.m. March 9, 2020

    - Seeking Alpha

  16. Loading more headlines...
/news/pressrelease/company/us/cvm

Press Releases on CVM

  1. CEL-SCI Corporation Issues Letter to Shareholders

    9:15 a.m. Sept. 15, 2020

    - BusinessWire - BZX

  2. LD Micro 360 Companies Set to Present this Week

    5:00 p.m. Aug. 31, 2020

    - ACCESSWIRE

  3. CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment

    8:30 a.m. July 24, 2020

    - BusinessWire - BZX

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.